Medindia

X

BioElectronics Announces Distribution Agreement for Sales In India

Thursday, July 17, 2008 General News J E 4
Advertisement
FREDERICK, Md., July 17 BioElectronicsCorporation (Pink Sheets: BIEL) announces today a new distribution agreementwith Piramal Healthcare Limited has been made for distribution ofBioElectronic's revolutionary ActiPatch product.

Piramal Healthcare Limited (earlier Nicholas Piramal India Limited) is oneof India's largest companies with strong brand management and salescapabilities. PHL has emerged among the leaders in Indian pharma with one ofthe widest product portfolios in India.

Andrew J. Whelan, CEO of BioElectronics Corporation, explains, "This is animportant and significant order for BioElectronics Corporation. We continueto be excited about developing strong sales in the international marketplace.Piramal Healthcare is an aggressive player and the right partner to help usroll our product out into one of the most populous countries in the world."

Dr. Swati Piramal, Director, Piramal Healthcare Ltd., said, "At Piramal webelieve that we should care for the world we share and serve. With theActipatch launch, we are delighted to bring a breakthrough technology to Indiato offer a cost effective healing solution." Actipatch(TM), the productmarketed by BioElectronics Corp. is changing the face of medicine and the waywe heal. Recently chosen as "One of 9 Medical Breakthroughs That May ChangeYour Life," by Medical Headway.com, ActiPatch is fast becoming the treatmentof choice for everything in soft tissue injuries including surgical recovery.

ActiPatch is a drug-free wafer thin patch with an embeddedbattery-operated microchip that delivers weeks of continuous pulsed RF therapyfor less than a dollar a day. The unique ActiPatch delivery system, usingpatented technology, provides a cost-effective, home use method that reducessoft tissue pain and swelling, and accelerates healing.

Piramal Healthcare will distribute ActiPatch in the Indian market both onmedical and retail levels in August 2008.

For more information visit http://www.bioelectronicscorp.com or call866-757-2284.

Information on ActiPatch and BioElectronics Corporation is available atthe following websites:

About Piramal Healthcare Limited

Piramal Healthcare Ltd. is one of India's largest pharmaceuticalcompanies, with a growth track record of above 30% CAGR since 1988. PiramalHealthcare had consolidated revenues of US$ 718 million in FY2008. The Companyis currently ranked 4th in the Indian market with a diverse product portfoliospanning nine therapeutic areas. The Company is also one of the largest custommanufacturing companies with a global footprint of assets across NorthAmerica, Europe and Asia. Piramal Healthcare is listed in India on theNational Stock Exchange (Ticker: PIRHEALTH) and the Bombay Stock Exchange(Ticker: 500302).

Safe Harbor Statement

This news release contains forward-looking statements related to futuregrowth and earnings opportunities. Such statements are based upon certainassumptions and assessments made by management in light of current conditions,expected future developments and other factors it believes to be appropriate.Actual results may differ as a result of factors over which the company has nocontrol.-- U.S. Consumer www.actipatchonline.com -- Podiatry: www.pemfpodiatry.com -- Plastic Surgery: www.plasticsurgeryrelief.com and www.makemeheal.com -- German orthopedic foot & ankle: www.diesfussexperten.de -- Italy and Switzerland: www.actipatch.it -- Canada: www.actipatchpaintherapy.ca -- Netherlands: www.actipatch.de -- Singapore & Malaysia: http://www.astonixlife.com/ -- BioElectronics Corp: http://www.bioelectronicscorp.com

SOURCE BioElectronics Corporation
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Arbel Medical has Completed a $4.5 million Round o...
S
Hologic, Inc. Accepts Shares of Third Wave Technol...